Clinical Trial Update: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma [Phase 3]

View source ↗

Summary

Ongoing Phase 3 clinical trial evaluating levocarnitine to protect the liver from chemotherapy in children with acute lymphoblastic leukemia or lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Lymphoblastic Leukemia Bcr-abl1 Positive
• Acute Lymphoblastic Leukemia Bcr-abl1-like
• Lymphoblastic Lymphoma
• Mixed Phenotype Acute Leukemia
• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• LEVOCARNITINE (levocarnitine)

Snippet

Sponsor: Children's Oncology Group | Conditions: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 3 | Status: RECRUITING